One-Stop Device Closure for Ventricular Septal Defect with Atrial Septal Defect Guided by Transesophageal

Jinghao Song1, Yuekun Sun1, Huaixue Mi1

  • 1Department of Cardiovascular Surgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Engineering Research Center for Heart Transplant and Material, 250014 Jinan, Shandong, China.

Insights

Transesophageal echocardiography-guided percardiac or percutaneous closure of ventricular septal defect (VSD) with atrial septal defect (ASD) is safe and effective. These one-stop treatments offer a valuable alternative for selected patients with complex congenital heart disease.

Area of Science:

  • Cardiology
  • Congenital Heart Disease Treatment
  • Minimally Invasive Cardiac Surgery

Background:

  • Ventricular septal defect (VSD) with atrial septal defect (ASD) represents a common and complex congenital heart anomaly.
  • Evaluating novel therapeutic strategies is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess the clinical efficacy and safety of transesophageal echocardiography (TEE)-guided percardiac or combined percutaneous techniques for treating VSD with ASD.
  • To evaluate these techniques across diverse patient anatomies.

Main Methods:

  • A retrospective cohort study of 40 patients with VSD and ASD from June 2015 to July 2023.
  • TEE-guided peratrial, perventricular, or combined percardiac/percutaneous approaches were utilized based on defect type.
  • Comprehensive follow-up included ECG, echocardiography, and X-ray at specified intervals post-surgery.

Main Results:

  • 100% surgical success rate with no reoperations required during follow-up.
  • Minor residual shunts and valve regurgitations observed in some cases resolved within 6 months.
  • No significant differences in adverse event rates were found among the three surgical approaches (p=0.957).

Conclusions:

  • TEE-guided percardiac or combined percutaneous device closure is a safe, effective, and feasible approach for one-stop treatment of VSD with ASD.
  • These minimally invasive techniques offer a valuable alternative therapy for carefully selected patients.
Abstract